Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
Randomized Trial of the NeoChord™ DS1000™ System Versus Open Surgical Repair
NeoChord
585 participants
Nov 3, 2016
INTERVENTIONAL
Conditions
Summary
The objective of this trial is to assess the safety and effectiveness of the study device in subjects with degenerative mitral valve disease receiving a mitral valve repair without cardiopulmonary bypass (treatment group) when compared to subjects receiving mitral valve repair using standard surgical techniques with cardiopulmonary bypass (control group).
Eligibility
Inclusion Criteria5
- Is a candidate for mitral valve repair with cardiopulmonary bypass
- Has Grade III moderate or Grade IV severe degenerative mitral valve regurgitation
- Primary segmental prolapse of the A2 or P2 segment or prolapse extending to an adjacent segment (P1, P3, A1, A3) who have a single eccentric regurgitant jet on echocardiogram
- Anterior leaflet covers at least 65% of anterior-posterior annular distance or an anterior leaflet that would provide sufficient coaptation after chord placement
- Anatomic and general suitability
Exclusion Criteria3
- Prior mitral valve surgery
- Concomitant cardiac procedures
- Other cardiac procedures within 3 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Trans-apical, beating heart repair of degenerative mitral valve insufficiency with artificial chordae implanted with the NeoChord DS1000
Surgical repair of degenerative mitral valve insufficiency with cardiopulmonary bypass, and annuloplasty ring and some form of leaflet repair or artificial chordae.
Locations(18)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02803957